Of interest, CSF3R T618I mutated CEBPAbi subset was uniformly sensitive to JAK inhibitors, as also reported in CSF3R T618I mutated cases in other related disorders, i.e. T acute lymphoblastic leukemia and CNL [34]. The gene discussed is CSF3R; the disease is acute lymphoblastic leukemia.